Scientists at Rutgers and other universities build technology that could lead to rapid discovery of new medicines and biomarkers hidden in genomes
Discovering the function of a gene requires cloning a DNA sequence and expressing it. Until now, this was performed on a one-gene-at-a-time basis, causing a bottleneck. Scientists at Rutgers University-New Brunswick in collaboration with Johns Hopkins University and Harvard Medical School have invented a technology to clone thousands of genes simultaneously and create massive libraries of proteins from DNA samples, potentially ushering in a new era of functional genomics.
“We think that the rapid, affordable, and high-throughput cloning of proteins and other genetic elements will greatly accelerate biological research to discover functions of molecules encoded by genomes and match the pace at which new genome sequencing data is coming out,” said Biju Parekkadan, an associate professor in the Department of Biomedical Engineering at Rutgers University-New Brunswick.
In a study published online today in the journal Nature Biomedical Engineering, the researchers showed that their technology – LASSO (long-adapter single-strand oligonucleotide) probes – can capture and clone thousands of long DNA fragments at once.
As a proof-of-concept, the researchers cloned more than 3,000 DNA fragments from E. coli bacteria, commonly used as a model organism with a catalogued genome sequence available.
“We captured about 95 percent of the gene targets we set out to capture, many of which were very large in DNA length, which has been challenging in the past,” Parekkadan said. “I think there will certainly be more improvements over time.”
They can now take a genome sequence (or many of them) and make a protein library for screening with unprecedented speed, cost-effectiveness and precision, allowing rapid discovery of potentially beneficial biomolecules from a genome.
In conducting their research, they coincidentally solved a longstanding problem in the genome sequencing field. When it comes to genetic sequencing of individual genomes, today’s gold standard is to sequence small pieces of DNA one by one and overlay them to map out the full genome code. But short reads can be hard to interpret during the overlaying process and there hasn’t been a way to sequence long fragments of DNA in a targeted and more efficient way. LASSO probes can do just this, capturing DNA targets of more than 1,000 base pairs in length where the current format captures about 100 base pairs.
The team also reported the capture and cloning of the first protein library, or suite of proteins, from a human microbiome sample. Shedding light on the human microbiome at a molecular level is a first step toward improving precision medicine efforts that affect the microbial communities that colonize our gut, skin and lungs, Parekkadan added. Precision medicine requires a deep and functional understanding, at a molecular level, of the drivers of healthy and disease-forming microbiota.
Today, the pharmaceutical industry screens synthetic chemical libraries of thousands of molecules to find one that may have a medicinal effect, said Parekkadan, who joined Rutgers’ School of Engineering in January.
“Our vision is to apply the same approach but rapidly screen non-synthetic, biological or ‘natural’ molecules cloned from human or other genomes, including those of plants, animals and microbes,” he said. “This could transform pharmaceutical drug discovery into biopharmaceutical drug discovery with much more effort.”
The next phase, which is underway, is to improve the cloning process, build libraries and discover therapeutic proteins found in our genomes, Parekkadan said.
The Latest on: Precision medicine
- Recent Advances in Precision Medicine Technologies, 2018 Report - ResearchAndMarkets.com on September 21, 2018 at 11:26 am
DUBLIN--(BUSINESS WIRE)--The "Recent Advances in Precision Medicine Technologies" report has been added to ResearchAndMarkets.com's offering. The Genetic Technology TechVision Opportunity Engine ... […]
- Genomic study brings us closer to precision medicine for type 2 diabetes on September 21, 2018 at 11:02 am
Most patients diagnosed with type 2 diabetes are treated with a "one-size-fits-all" protocol that is not tailored to each person's physiology and may leave many cases inadequately managed. […]
- Analysis: Is 'precision medicine' the answer to cancer? Not precisely on September 21, 2018 at 6:22 am
Facing incurable breast cancer at age 55, MaryAnne DiCanto put her faith in "precision medicine—in which doctors try to match patients with drugs that target the genetic mutations in their tumors. […]
- Precision Medicine's Promise - Lost In Translation on September 21, 2018 at 5:13 am
Dr. Charles Dinerstein, M.D., M.B.A., F.A.C.S. is Senior Medical Fellow at the American Council on Science and Health. A retired vascular surgeon, he also writes a "more philosophic" blog at Surgical ... […]
- Precision Medicine Market - Forecasts from 2018 to 2023 with Profiles of Major Players - Nordic Bioscience A/S, Nanostring Technologies, Inc., and Laboratory Corporation of ... on September 20, 2018 at 11:07 am
DUBLIN--(BUSINESS WIRE)--The "Precision Medicine Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The precision medicine market is projected to grow at ... […]
- Global Precision Medicine Market 2018-2023 - Market Projected to Reach $87.87 Billion on September 20, 2018 at 9:00 am
The "Precision Medicine Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The precision medicine market is projected to grow at a CAGR of 8.47% to ... […]
- Is 'precision medicine' the answer to cancer? Not precisely on September 19, 2018 at 8:33 am
Facing incurable breast cancer at age 55, MaryAnne DiCanto put her faith in "precision medicine" in which doctors try to match patients with drugs that target the genetic mutations in their tumors. Sh... […]
- Strategic Evaluation of Precision Medicine: Country Analysis for Emerging Opportunities on September 18, 2018 at 12:53 pm
Strategic Evaluation of Precision Medicine Market by BIS Research This strategic report provides a multidimensional view of the strategic evolution in the field of precision medicine.The purpose of th... […]
- Global Strategic Evaluation of Precision Medicine Markets 2016-2026 & Country Analysis for Emerging Opportunities on September 18, 2018 at 1:32 am
The "Strategic Evaluation of Precision Medicine: Country Analysis for Emerging Opportunities" report has been added to ResearchAndMarkets.com's offering. In 2017, the global precision medicine market ... […]
- Precision Medicine Comes of Age on September 18, 2018 at 12:07 am
Finding individual differences in tumors is key to treating the right patient with the right medicine at the right time, researchers say Discover world-changing science. Explore our digital archive ba... […]
via Google News and Bing News